Logo image of CPT

CAMDEN PROPERTY TRUST (CPT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CPT - US1331311027 - REIT

101.69 USD
-1 (-0.97%)
Last: 12/9/2025, 4:52:14 PM
101.69 USD
0 (0%)
After Hours: 12/9/2025, 4:52:14 PM
Fundamental Rating

3

CPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 20 industry peers in the Residential REITs industry. CPT has a medium profitability rating, but doesn't score so well on its financial health evaluation. CPT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CPT had positive earnings in the past year.
In the past year CPT had a positive cash flow from operations.
Each year in the past 5 years CPT has been profitable.
In the past 5 years CPT always reported a positive cash flow from operatings.
CPT Yearly Net Income VS EBIT VS OCF VS FCFCPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

The Return On Assets of CPT (2.97%) is comparable to the rest of the industry.
With a Return On Equity value of 5.92%, CPT perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
The Return On Invested Capital of CPT (2.64%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CPT is in line with the industry average of 2.59%.
Industry RankSector Rank
ROA 2.97%
ROE 5.92%
ROIC 2.64%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
CPT Yearly ROA, ROE, ROICCPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

CPT has a Profit Margin (17.11%) which is in line with its industry peers.
CPT's Profit Margin has declined in the last couple of years.
The Operating Margin of CPT (18.25%) is comparable to the rest of the industry.
CPT's Operating Margin has declined in the last couple of years.
CPT's Gross Margin of 61.28% is fine compared to the rest of the industry. CPT outperforms 75.00% of its industry peers.
CPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.25%
PM (TTM) 17.11%
GM 61.28%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
CPT Yearly Profit, Operating, Gross MarginsCPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CPT is destroying value.
The number of shares outstanding for CPT has been reduced compared to 1 year ago.
The number of shares outstanding for CPT has been increased compared to 5 years ago.
The debt/assets ratio for CPT has been reduced compared to a year ago.
CPT Yearly Shares OutstandingCPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CPT Yearly Total Debt VS Total AssetsCPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CPT has an Altman-Z score of 1.51. This is a bad value and indicates that CPT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CPT (1.51) is better than 75.00% of its industry peers.
CPT has a debt to FCF ratio of 9.72. This is a negative value and a sign of low solvency as CPT would need 9.72 years to pay back of all of its debts.
CPT has a better Debt to FCF ratio (9.72) than 95.00% of its industry peers.
CPT has a Debt/Equity ratio of 0.82. This is a neutral value indicating CPT is somewhat dependend on debt financing.
CPT has a better Debt to Equity ratio (0.82) than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 9.72
Altman-Z 1.51
ROIC/WACC0.36
WACC7.32%
CPT Yearly LT Debt VS Equity VS FCFCPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

CPT has a Current Ratio of 0.07. This is a bad value and indicates that CPT is not financially healthy enough and could expect problems in meeting its short term obligations.
CPT has a worse Current ratio (0.07) than 80.00% of its industry peers.
A Quick Ratio of 0.07 indicates that CPT may have some problems paying its short term obligations.
CPT has a Quick ratio of 0.07. This is in the lower half of the industry: CPT underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
CPT Yearly Current Assets VS Current LiabilitesCPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

CPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.37%.
Measured over the past 5 years, CPT shows a small growth in Earnings Per Share. The EPS has been growing by 0.43% on average per year.
The Revenue has been growing slightly by 1.55% in the past year.
CPT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.46% yearly.
EPS 1Y (TTM)-42.37%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%194.12%
Revenue 1Y (TTM)1.55%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.18%

3.2 Future

Based on estimates for the next years, CPT will show a decrease in Earnings Per Share. The EPS will decrease by -4.33% on average per year.
The Revenue is expected to grow by 4.51% on average over the next years.
EPS Next Y29.74%
EPS Next 2Y-18.6%
EPS Next 3Y-4.33%
EPS Next 5YN/A
Revenue Next Year2.18%
Revenue Next 2Y2.06%
Revenue Next 3Y2.81%
Revenue Next 5Y4.51%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CPT Yearly Revenue VS EstimatesCPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
CPT Yearly EPS VS EstimatesCPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 49.85, the valuation of CPT can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CPT is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CPT to the average of the S&P500 Index (26.34), we can say CPT is valued expensively.
A Price/Forward Earnings ratio of 81.64 indicates a quite expensive valuation of CPT.
CPT's Price/Forward Earnings ratio is in line with the industry average.
CPT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.56.
Industry RankSector Rank
PE 49.85
Fwd PE 81.64
CPT Price Earnings VS Forward Price EarningsCPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPT indicates a somewhat cheap valuation: CPT is cheaper than 75.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CPT is valued cheaper than 85.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.13
EV/EBITDA 16.4
CPT Per share dataCPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CPT's earnings are expected to decrease with -4.33% in the coming years. This may justify a cheaper valuation.
PEG (NY)1.68
PEG (5Y)115.64
EPS Next 2Y-18.6%
EPS Next 3Y-4.33%

5

5. Dividend

5.1 Amount

CPT has a Yearly Dividend Yield of 4.02%, which is a nice return.
Compared to an average industry Dividend Yield of 7.26, CPT is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.31, CPT pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.02%

5.2 History

The dividend of CPT has a limited annual growth rate of 4.99%.
CPT has been paying a dividend for at least 10 years, so it has a reliable track record.
CPT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.99%
Div Incr Years7
Div Non Decr Years14
CPT Yearly Dividends per shareCPT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

CPT pays out 170.91% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of CPT has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP170.91%
EPS Next 2Y-18.6%
EPS Next 3Y-4.33%
CPT Yearly Income VS Free CF VS DividendCPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CPT Dividend Payout.CPT Dividend Payout, showing the Payout Ratio.CPT Dividend Payout.PayoutRetained Earnings

CAMDEN PROPERTY TRUST

NYSE:CPT (12/9/2025, 4:52:14 PM)

After market: 101.69 0 (0%)

101.69

-1 (-0.97%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-04 2026-02-04/amc
Inst Owners98.14%
Inst Owner Change2.23%
Ins Owners1.25%
Ins Owner Change0%
Market Cap10.82B
Revenue(TTM)1.57B
Net Income(TTM)268.55M
Analysts72.67
Price Target118.99 (17.01%)
Short Float %3.81%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield 4.02%
Yearly Dividend4.15
Dividend Growth(5Y)4.99%
DP170.91%
Div Incr Years7
Div Non Decr Years14
Ex-Date09-30 2025-09-30 (1.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)121.26%
Min EPS beat(2)-0.59%
Max EPS beat(2)243.11%
EPS beat(4)2
Avg EPS beat(4)58.98%
Min EPS beat(4)-12.31%
Max EPS beat(4)243.11%
EPS beat(8)4
Avg EPS beat(8)90.86%
EPS beat(12)8
Avg EPS beat(12)76.46%
EPS beat(16)9
Avg EPS beat(16)99.25%
Revenue beat(2)0
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-1.74%
Max Revenue beat(2)-0.45%
Revenue beat(4)0
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-1.74%
Max Revenue beat(4)-0.45%
Revenue beat(8)0
Avg Revenue beat(8)-1.04%
Revenue beat(12)0
Avg Revenue beat(12)-0.97%
Revenue beat(16)2
Avg Revenue beat(16)5.1%
PT rev (1m)-3.72%
PT rev (3m)-5.37%
EPS NQ rev (1m)8.9%
EPS NQ rev (3m)7.09%
EPS NY rev (1m)44.49%
EPS NY rev (3m)93.59%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-0.83%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.19%
Valuation
Industry RankSector Rank
PE 49.85
Fwd PE 81.64
P/S 6.9
P/FCF 28.13
P/OCF 13.83
P/B 2.39
P/tB 2.39
EV/EBITDA 16.4
EPS(TTM)2.04
EY2.01%
EPS(NY)1.25
Fwd EY1.22%
FCF(TTM)3.62
FCFY3.56%
OCF(TTM)7.35
OCFY7.23%
SpS14.75
BVpS42.63
TBVpS42.63
PEG (NY)1.68
PEG (5Y)115.64
Graham Number44.24
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 5.92%
ROCE 3.34%
ROIC 2.64%
ROICexc 2.65%
ROICexgc 2.73%
OM 18.25%
PM (TTM) 17.11%
GM 61.28%
FCFM 24.51%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
ROICexc(3y)2.77%
ROICexc(5y)2.72%
ROICexgc(3y)2.85%
ROICexgc(5y)2.8%
ROCE(3y)3.46%
ROCE(5y)3.32%
ROICexgc growth 3Y0.86%
ROICexgc growth 5Y-2.21%
ROICexc growth 3Y1.1%
ROICexc growth 5Y-2.02%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
F-Score5
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 9.72
Debt/EBITDA 4.19
Cap/Depr 65.56%
Cap/Sales 25.33%
Interest Coverage 2.06
Cash Conversion 87.62%
Profit Quality 143.24%
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 1.51
F-Score5
WACC7.32%
ROIC/WACC0.36
Cap/Depr(3y)72.34%
Cap/Depr(5y)87.06%
Cap/Sales(3y)27.91%
Cap/Sales(5y)32.43%
Profit Quality(3y)124.82%
Profit Quality(5y)99.59%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.37%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%194.12%
EPS Next Y29.74%
EPS Next 2Y-18.6%
EPS Next 3Y-4.33%
EPS Next 5YN/A
Revenue 1Y (TTM)1.55%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.18%
Revenue Next Year2.18%
Revenue Next 2Y2.06%
Revenue Next 3Y2.81%
Revenue Next 5Y4.51%
EBIT growth 1Y-5.72%
EBIT growth 3Y9.54%
EBIT growth 5Y3.5%
EBIT Next Year209.13%
EBIT Next 3Y47.87%
EBIT Next 5Y37.45%
FCF growth 1Y3.98%
FCF growth 3Y36.84%
FCF growth 5Y20.83%
OCF growth 1Y1.43%
OCF growth 3Y10.3%
OCF growth 5Y6.88%

CAMDEN PROPERTY TRUST / CPT FAQ

What is the fundamental rating for CPT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CPT.


Can you provide the valuation status for CAMDEN PROPERTY TRUST?

ChartMill assigns a valuation rating of 3 / 10 to CAMDEN PROPERTY TRUST (CPT). This can be considered as Overvalued.


Can you provide the profitability details for CAMDEN PROPERTY TRUST?

CAMDEN PROPERTY TRUST (CPT) has a profitability rating of 4 / 10.


Can you provide the financial health for CPT stock?

The financial health rating of CAMDEN PROPERTY TRUST (CPT) is 3 / 10.


What is the earnings growth outlook for CAMDEN PROPERTY TRUST?

The Earnings per Share (EPS) of CAMDEN PROPERTY TRUST (CPT) is expected to grow by 29.74% in the next year.